My TakeThis is pretty interesting, the way I read this, is that Gastle is spinning this venture into a new company with Microbix holding a 80% stake in the Joint Venture. Therefore, we the share holders of Microbix also own a portion of this joint venture.
This allows Gastle the ability for private investors to invest into this joint venture without Microbix giving up any other of its proprietory assets. Also, the joint venture will use the VIRUSMAX technology.
Therefore, we as share holders will hopefully benefit in two ways. With Microbix, and with the 80% ownership of Crucible.
Thats the way I see it.
Sounds good.
Would love to hear comments.